Search results
Jul 18, 2024 · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Find information on our research locations and corporate offices in US. 769 million lives touched by our products. Join us. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4] [5]
Find the latest Novartis AG (NVS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Transforming people’s lives by reimagining medicine. | At Novartis US, our mission is to reimagine medicine and discover new ways to improve and extend people's lives.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Search for careers at Novartis and discover our diverse and inclusive teams where we collaborate to bring innovative products to life.
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered...
Advancing digital and data-led approaches to population health. The Novartis Foundation focuses on the world’s most pressing health challenges: cardiovascular disease and health inequity.
These resources provide an overview of key concepts around precision medicine as well as principles of biomarker testing and personalized therapies. Topics related to improving biomarker test availability are also covered.
